Health AI Central
Share:
Peer-Reviewed Publication
Clinicoecon Outcomes Res2018;10157-167.January 1, 2018Journal Article

Analysis of utilization patterns and associated costs of the breast imaging and diagnostic procedures after screening mammography.

Anna Vlahiotis1, Brian Griffin2, A Thomas Stavros3, Jay Margolis1
1Value Based Care, Outcomes Research, Truven Health Analytics, an IBM Company, Bethesda, MD USA.
2Value Based Care, Outcomes Research, Truven Health Analytics, an IBM Company, Newark, NJ, USA.
3Seno Medical Instruments, Inc., San Antonio, TX, USA.
PubMed PMC DOI PDF

Abstract

BACKGROUND: Little data exist on real-world patterns and associated costs of downstream breast diagnostic procedures following an abnormal screening mammography or clinical exam. OBJECTIVES: To analyze the utilization patterns in real-world clinical settings for breast imaging and diagnostic procedures, including the frequency and volume of patients and procedures, procedure sequencing, and assoc…

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Create Free AccountSign In

Want unlimited research access? See Pro plans

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.